Diagnosis and treatment of metastatic hormone sensitive prostate cancer: a case report
10.3760/cma.j.cn112330-20210908-00006
- VernacularTitle:转移性激素敏感性前列腺癌诊疗一例报告
- Author:
Biao DONG
1
;
Wugong QU
;
Shuanbao YU
;
Xuepei ZHANG
Author Information
1. 郑州大学第一附属医院泌尿外科，郑州 450000
- Keywords:
Prostate cancer;
Hormone sensitive;
Metastatic;
Androgen deprivation therapy
- From:
Chinese Journal of Urology
2021;42(Z2):18-20
- CountryChina
- Language:Chinese
-
Abstract:
Androgen deprivation therapy is one of the main therapies for metastatic hormone sensitive prostate cancer. A case of metastatic hormone sensitive prostate cancer was reported, a 55 year old patient was admitted to the hospital due to increased PSA in physical examination. PET-CT examination showed multiple clinical metastases in the left neck, abdominal cavity, retroperitoneal cavity and pelvic cavity. Bone metastases occurred in the right fourth rib and the left sixth and seventh ribs; after 8 months of endocrine therapy and the second generation of anti androgen therapy, the reexamination of imaging examination showed that the prostate lesions, seminal vesicle invasion, bone metastases were all subsided.
